Relief Cardiovascular is an inQB8 medical technologies portfolio company.
Relief Cardiovascular has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Relief Cardiovascular's investors include Broadview Ventures, Advent Life Sciences, MedTech Innovator, Pacific Health Ventures, Heartwork Capital.
Relief Cardiovascular is headquartered in Costa Mesa, United States.
Relief Cardiovascular is an inQB8 medical technologies portfolio company.
Relief Cardiovascular is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Relief Cardiovascular — Funding & Investors." VCBacked, January 8, 2025, https://www.vcbacked.co/company/relief-cardiovascular. Accessed October 30, 2026.
VCBacked. (2025). Relief Cardiovascular — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/relief-cardiovascular
{{cite web |title=Relief Cardiovascular — Funding & Investors |url=https://www.vcbacked.co/company/relief-cardiovascular |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated